Pages that link to "Q44635867"
Jump to navigation
Jump to search
The following pages link to Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase (Q44635867):
Displaying 49 items.
- Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development (Q26861674) (← links)
- Targeted treatment of chronic myeloid leukemia: role of imatinib. (Q33915973) (← links)
- Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase (Q34443523) (← links)
- Recent advances in the understanding of mastocytosis: the role of KIT mutations. (Q34635424) (← links)
- An uneventful pregnancy and delivery, in a case with chronic myeloid leukemia on imatinib (Q35610852) (← links)
- Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance (Q35816396) (← links)
- Imatinib mesylate in the treatment of chronic myelogenous leukemia (Q35828732) (← links)
- Riddle: what do aplastic anemia, acute promyelocytic leukemia, and chronic myeloid leukemia have in common? (Q35882311) (← links)
- How I treat newly diagnosed chronic phase CML (Q37027767) (← links)
- Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case (Q37280862) (← links)
- Human induced pluripotent stem cells from basic research to potential clinical applications in cancer (Q37316328) (← links)
- Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate (Q37738448) (← links)
- The Biology of Chronic Myelogenous Leukemia Progression: Who, What, Where, and Why? (Q37952907) (← links)
- How I treat newly diagnosed chronic myeloid leukemia in 2015. (Q38265086) (← links)
- Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. (Q38447382) (← links)
- Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015. (Q38598820) (← links)
- Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report (Q38685696) (← links)
- Successful Bosutinib Experience in an Elderly Acute Lymphoblastic Leukemia Patient with Suspected Central Nervous System Involvement Transformed from Chronic Myeloid Leukemia (Q40178701) (← links)
- The Challenge of t (6;9) and FLT3-Positive Acute Myelogenous Leukemia in a Young Adult (Q42391046) (← links)
- Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options. (Q42650776) (← links)
- Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches. (Q43078241) (← links)
- Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. (Q43138991) (← links)
- Additional chromosomal abnormalities in Philadelphia-positive chronic myeloid leukemia (Q43197897) (← links)
- Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib. (Q43266877) (← links)
- Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome (Q44826305) (← links)
- Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods. (Q45043877) (← links)
- Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under-reported and does it have any clinical significance? (Q45112330) (← links)
- Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate (Q45173736) (← links)
- Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha (Q45206587) (← links)
- Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up (Q45301057) (← links)
- t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia (Q46074323) (← links)
- Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform (Q46179041) (← links)
- Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors (Q46192237) (← links)
- Cytogenetic abnormalities without evidence of relapse after treatment with imatinib and stem cell transplantation in a patient with Ph-positive ALL. (Q46376561) (← links)
- Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL. (Q46947501) (← links)
- Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment (Q48186139) (← links)
- Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia (Q48333828) (← links)
- Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update (Q49993294) (← links)
- [Clinical observation of chromosomal abnormalities in Ph negative cells of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors]. (Q53085023) (← links)
- Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia (Q53264656) (← links)
- Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant. (Q53469467) (← links)
- Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second‐line agents, and beyond (Q54607049) (← links)
- Chronic Myeloid Leukemia: Beyond BCR-ABL1 (Q58102326) (← links)
- Characterization of Ph-negative abnormal clones emerging during imatinib therapy (Q58449075) (← links)
- Cytogenetic evolution patterns in CML post-SCT (Q79520861) (← links)
- Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy (Q80777939) (← links)
- Myelodysplastic Syndrome with Ph Negative Monosomy 7 Chromosome following Transient Bone Marrow Dysplasia during Imatinib Treatment for Chronic Myeloid Leukemia (Q83525115) (← links)
- Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia (Q90084743) (← links)
- [The significance of non-Ph chromosome in chronic myelogenous leukemia] (Q99563212) (← links)